In this short video, we build a small 2x2 home in Minecraft, proving that even the tiniest space can become a functional and cozy shelter. Using smart block placement and creative design, this compact ...

The FDA has approved oral acalabrutinib (Calquence, AstraZeneca) in combination with venetoclax (Venclexta, AbbVie and Genentech) for the first-line treatment of adults with chronic lymphocytic ...

AMPLIFY showed improved PFS for acalabrutinib/venetoclax versus FCR or BR, with HR 0.65 and median PFS not estimable versus 47.6 months at 42.6-month follow-up ...

The FDA approved acalabrutinib (Calquence) plus venetoclax (Venclexta) for previously untreated chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma as the first all-oral, fixed-duration ...

AstraZeneca has secured a key regulatory win in its effort to reclaim the lead in the BTK inhibitor market, with the FDA approving its combination of Calquence plus Venclexta as the first all-oral, ...

FDA cleared acalabrutinib plus venetoclax as the only all-oral, fixed-dose combination option for first-line, treatment-naïve CLL/SLL. Phase 3 AMPLIFY showed superior PFS versus chemoimmunotherapy, ...

Chronic lymphocytic leukemia (CLL), is a type of cancer that affects a type of white blood cell in your body called a lymphocyte. White blood cells are made in your bone marrow and help your body ...

Scientists who study chronic pain have long puzzled over a particular type of scenario: A man and woman get into a car accident and sustain the same injuries. But the woman experiences long-lasting ...

Chronic pain might quietly push people toward developing high blood pressure—and the more widespread the pain, the greater the danger. A massive analysis of over 200,000 adults uncovered strong links ...

The authors do not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and have disclosed no relevant affiliations beyond their ...

Described for the first time in the 1940s, lipedema has long been misunderstood, often mistaken for common obesity or lymphedema and frequently treated as a cosmetic issue. This has produced chronic ...